GleamWall
中文EN

PRPH ProPhase Labs, Inc.

Pharmaceutical Preparations · OTC · SEC CIK 868278 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY138.9%
TTM net income YoY45.8%
TTM EPS YoY91.5%
Revenue 3-yr CAGR-63.4%
Net income 3-yr CAGR—

Margins

Gross margin16.8%
Operating margin-404.5%
Net margin-583.9%
FCF margin—
EBITDA margin-320.1%

Returns

ROE-539.7%
ROA-45.2%
ROIC (approx.)-302.2%
Asset turnover0.08x

Leverage & solvency

Liabilities / assets105.4%
Debt / equity—
Current ratio0.05x
Interest coverage-2.15x

Cash quality & payout

Operating cash flow / net income0.25x
Accruals ratio-34.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$4.34M$6.77M
Cost of revenue$2.96M$6.92M
Gross profit$1.38M-$150,000
R&D expense$107,000$594,000
SG&A expense$19.32M$37.88M
Operating income-$18.05M-$38.63M
Interest expense$6.93M$3.35M
Pretax income-$23.39M-$42.33M
Income tax$0$7.20M
Net income-$14.74M-$53.36M
EBITDA-$13.21M-$32.44M
EPS (basic)-1.74-26.68
EPS (diluted)-1.74-26.68
Weighted avg. shares (diluted)8.49M2.00M
Banking
Provision for credit losses—$0
Balance sheet
Cash & equivalents$90,000$678,000
Short-term investments$0$3.13M
Receivables$1.54M$20.06M
Inventory$70,000$1.14M
Current assets$3.15M$30.64M
PP&E, net$2.03M$7.50M
Goodwill$3.97M$5.23M
Intangibles$7.17M$9.75M
Total assets$59.87M$63.20M
Current liabilities$53.08M$32.13M
Short-term debt—$3.21M
Total liabilities$56.36M$55.85M
Shareholders' equity$3.51M$7.35M
Shares outstanding8.97M2.99M
Cash flow statement
Operating cash flow-$8.34M-$17.54M
Capital expenditure$0$906,000
Free cash flow-$8.34M-$18.44M
Investing cash flow$920,000$2.42M
Financing cash flow$6.84M$14.19M
Depreciation & amortization$4.83M$6.19M
Stock-based compensation$1.89M$3.64M
Share buybacks—$0

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.